Abstract
Hyperuricemia is the main cause of gout, an inflammation induced by uric acid deposition in joints. Drugs available present side effects, so there is a need for new treatment alternatives. Lychnophora species are used in folk medicine to treat inflammation, rheumatism and muscle pain. Goyazensolide (10 mg/kg), eremantholide C (25 mg/kg) and lychnopholide (25 mg/kg), sesquiterpene lactones isolated from Lychnophora species were previously studied and showed anti-hyperuricemic effects in mice. However, the mechanisms of this effect were not elucidated. The methodology of this study consisted in treatment of hyperuricemic-induced rats, and comparison between control groups, clinically used anti-hyperuricemic drugs and sesquiterpene lactones. Urine and blood were collected for uric acid quantification. Xanthine oxidase inhibition was measured in liver homogenates. Results showed that all evaluated sesquiterpene lactones presented anti-hyperuricemic activity at the doses of 5 and 10 mg/kg and can act through one or both mechanisms, depending on the dose administrated. Goyazensolide and lychnopholide at dose of 5 mg/kg showed important uricosuric effect. Goyazensolide and lychnopholide at dose of 10 mg/kg, and eremantholide C (5 and 10 mg/kg) presented notable inhibition of hepatic xanthine oxidase activity and uricosuric effect. Thus, these sesquiterpene lactones are promising hypouricemic agent to treat hyperuricemia and gout.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.
Chaves, T.L, Ricardo, L., Paula-Souza, J.D., Brandão, M.D.G.L., 2015. Useful Brazilian plants under the view of the writer-naturalist João Guimarães Rosa. Rev. Bras. Farmacogn. 25, 437–444.
Chicaro, P., Pinto, E., Colepicolo, P., Lopes, J.L.C., Lopes, N.P., 2004. Flavonoids from Lychnophorapasserina (Asteraceae): potential antioxidants and UV-protectants. Biochem. Syst. Ecol. 32, 239–243.
Choi, H.K., Atkinson, K., Karlson, E.W., Willett, W., Curhan, G., 2004. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 350, 1093–1103.
Cragg, G.M., Newman, D.J., 2013. Natural products: a continuing source of novel drug leads. BBA-Gen. Subj. 1830, 3670–3695.
Crittenden, D.B., Pillinger, M.H., 2012. The year in gout: 2011-2012. Bull NYU Hosp. Jt. Dis. 70, 145–151.
De Souza, M.R., de Paula, CA., de Resende, M.L.P., Grabe-Guimarães, A., de Souza Filho, J.D., Saúde-Guimarães, DA, 2012. Pharmacological basis for use of Lychnophora trichocarpha in gouty arthritis: anti-hyperuricemic and antiinflammatory effects of its extract, fraction andconstituents. J. Ethnopharmacol. 142, 845–850.
Dubchack, N., Falasca, G.F., 2010. New and improved strategies forthe treatment of gout. Int. J. Nephrol. Renovasc. Dis. 3, 145–166.
Ferrari, F.C., Ferreira, L.C., de Souza, M.R., Grabe-Guimarães, A., Paula, CA., Rezende, S.A., Saúde-Guimarães, D.A., 2013. Anti-inflammatory sesquiterpene lactones from Lychnophora trichocarpha Spreng (Brazilian arnica). Phytother. Res. 27, 384–389.
Ferrari, F.C., Lima, R.D.C.L., Ferraz-Filha, Z.S., Barros, C.H., Araújo, M.C.D.P.M., Saúde-Guimarães, D.A., 2016. Effects of Pimenta pseudocaryophyllus extracts on gout: antiinflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuricaction. J. Ethnopharmacol. 180, 37–42.
Gobbo-Neto, L., Lopes, N.P., 2007. Plantas medicinais: fatores de influência no con-teúdode metabólitos secundários. Quim. Nova 30, 374–381.
Haidari, F., Rashidi, M.R., Keshavarz, S.A., Mahboob, S.A., Eshraghian, M.R., Shahi, M.M., 2008. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak. J. Biol. Sci. 11, 1779–1784.
Hall, I.H., Scoville, J.P., Reynolds, D.J., Simlot, R., Duncan, P., 1990. Substituted cyclic imides as potential anti-gout agents. Life Sci. 46, 1923–1927.
Harrold, L.R., Mazor, K.M., Peterson, D., Naz, N., Firneno, C., Yood, R.A., 2012. Patients’ knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet. Disord. 13, https://doi.org/10.1186/1471-2474-13-180.
Keles, L.C., Melo, N.I.D., Aguiar, G.D.P., Wakabayashi, K.A.L., Carvalho, C.E.D., Cunha, W.R., Crotti, A.E.M., Lopes, J.L.C., Lopes, N.P., 2010. Lychnophorinae (Asteraceae): a survey of its chemical constituents and biological activities. Quim. Nova 33, 2245–2260.
Kim, S.C., Newcomb, C., Margolis, D., Roy, J., Hennessy, S., 2013. Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res. 65, 578–584.
Murugaiyah, V., Chan, K.L., 2009. Mechanisms of antihyperuricemic effect of Phyl-lanthus niruri and its lignanconstituents. J. Ethnopharmacol. 124, 233–239.
Reinders, M.K., Van Roon, E.N., Jansen, T.L., Delsing, J., Griep, E.N., Hoekstra, M., van de Laar, M.A.F.J., Brouwers, J.R., 2009. Efficacy and tolerability of urate lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Ann. Rheum. Dis. 68, 51–56.
Rees, F., Jenkins, W., Doherty, M., 2013. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann. Rheum. Dis. 72, 826–830.
Rees, F., Hui, M., Doherty, M., 2014. Optimizing current treatment of gout. Nat. Rev. Rheumatol. 10, 271–283.
Saúde, D.A., Raslan, D.S., Souza Filho, J.D., Oliveira, A.B.D., 1998. Constituents from the aerial parts of Lychnophora trichocarpha. Fitoterapia 69, 90–91.
Saúde, D.A., Barrero, A.F., Oltra, J.E., Justicia, J., Raslan, D.S., Silva, E.A., 2002. Atividade antibacteriana de furanoeliangolidos. Rev. Bras. Farmacogn. 12, 7–10.
Saúde-Guimarães, D.A., Raslan, D.S., Oliveira, A.B., 2014. In vitro antitumor activity of sesquiterpene lactones from Lychnophora trichocarpha. Rev. Bras. Pl. Med. 16, 275–282.
Smith, E.U.R., Diaz-Torne, C., Perez-Ruiz, F., March, L.M., 2010. Epidemiology of gout: an update. Best Pract. Res. Clin. Rheumatol. 24, 811–827.
Terkeltaub, R.A., 2003. Clinical practice gout. N. Engl. J. Med. 349, 1647–1655.
Ugoline, B.C.D.A., Souza, J.D., Ferrari, F.C., Ferraz-Filha, Z.S., Coelho, G.B., Saúde-Guimarães, D.A., 2017. The influence of seasonality on the content of goyazensolide and on anti-inflammatory and anti-hyperuricemic effects of the ethanolic extract of Lychnophora passerina (Brazilian arnica). J. Ethnopharmacol. 198, 444–450.
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V., Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., McCarthy, G., Netter, P., Nuki, G., Perez-Ruiz, F., Pignone, A., Pimentão, J., Punzi, L., Roddy, E., Uhlig, T., McCarthy, G., 2006. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65, 1312–1324.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bernardes, A.C.F.P.F., Coelho, G.B., de Araújo, M.C.P.M. et al. In vivo anti-hyperuricemic activity of sesquiterpene lactones from Lychnophora species. Rev. Bras. Farmacogn. 29, 241–245 (2019). https://doi.org/10.1016/j.bjp.2018.12.008
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.bjp.2018.12.008